Twist Bioscience Corporation Common Stock TWST
Analyst Ratings
- Consensus
- Buy — 8 Buy · 1 Hold · 0 Sell (9 analysts)
- Avg. Price Target
- $94.89 (-34.8% downside)
Key Stats
- Today's Range
- $135.05 – $145.93
- 50-Day Range
- $68.45 – $145.93
- 52-Week Range
- $23.30 – $145.93
- Volume
- 1.80 million shs
- Average Volume
- 1.57 million shs
- Market Cap
- $8.55 billion
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 19.18
- Price / Sales
- 19.80
Short Interest
- Short Interest
- 0.08%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- $431.80 million
- Net Income
- $-136,717,000
- Net Margin
- -31.66%
- Return on Equity
- -30.67%
- Debt-to-Equity
- —
About Twist Bioscience Corporation Common Stock
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
Related Stocks
Compare head-to-head: TWST vs AMGN·TWST vs MRNA·TWST vs HALO·TWST vs KYMR
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.